当前位置：
X-MOL 学术
›
Thorac. Cancer
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
High expression of KITLG is a new hallmark activating the MAPK pathway in type A and AB thymoma.
Thoracic Cancer ( IF 2.3 ) Pub Date : 2020-05-28 , DOI: 10.1111/1759-7714.13486 Zhaoyu Yang 1 , Shinan Liu 1 , Yuanguo Wang 1 , Yuan Chen 1 , Peng Zhang 1 , Yimei Liu 1 , Hui Zhang 1 , Peng Zhang 1 , Ziyou Tao 1 , Kai Xiong 1
Thoracic Cancer ( IF 2.3 ) Pub Date : 2020-05-28 , DOI: 10.1111/1759-7714.13486 Zhaoyu Yang 1 , Shinan Liu 1 , Yuanguo Wang 1 , Yuan Chen 1 , Peng Zhang 1 , Yimei Liu 1 , Hui Zhang 1 , Peng Zhang 1 , Ziyou Tao 1 , Kai Xiong 1
Affiliation
KIT proto‐oncogene ligand (KITLG) is a pleiotropic factor which is found in diverse cancers and is involved in cell proliferation, differentiation, and survival. However, the value of KITLG in thymoma remains unclear.
中文翻译：
KITLG的高表达是激活A型和AB型胸腺瘤MAPK途径的新标志。
KIT原癌基因配体（KITLG）是一种多效性因子，存在于多种癌症中，并参与细胞增殖，分化和存活。但是，KITLG在胸腺瘤中的价值尚不清楚。
更新日期：2020-05-28
中文翻译：
KITLG的高表达是激活A型和AB型胸腺瘤MAPK途径的新标志。
KIT原癌基因配体（KITLG）是一种多效性因子，存在于多种癌症中，并参与细胞增殖，分化和存活。但是，KITLG在胸腺瘤中的价值尚不清楚。
京公网安备 11010802027423号